Rapport Therapeutics, Inc. RAPP Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Rapport Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The official record: Rapport Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rapport Therapeutics, Inc.'s total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rapport Therapeutics, Inc.'s total liabilities & equity?
- Rapport Therapeutics, Inc. (RAPP) reported total liabilities & equity of $497.6M in Q1 2026.
- How has Rapport Therapeutics, Inc.'s total liabilities & equity changed year-over-year?
- Rapport Therapeutics, Inc.'s total liabilities & equity increased by 64.7% year-over-year, from $302.05M to $497.6M.
- What is the long-term trend for Rapport Therapeutics, Inc.'s total liabilities & equity?
- Over 2 years (2023 to 2025), Rapport Therapeutics, Inc.'s total liabilities & equity has grown at a 81.6% compound annual growth rate (CAGR), from $155.42M to $512.43M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.